BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 19451440)

  • 1. Health-related quality of life as a survival predictor for patients with localized head and neck cancer treated with radiation therapy.
    Meyer F; Fortin A; Gélinas M; Nabid A; Brochet F; Têtu B; Bairati I
    J Clin Oncol; 2009 Jun; 27(18):2970-6. PubMed ID: 19451440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis.
    Siddiqui F; Pajak TF; Watkins-Bruner D; Konski AA; Coyne JC; Gwede CK; Garden AS; Spencer SA; Jones C; Movsas B
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):353-60. PubMed ID: 17889449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy.
    Fang FM; Liu YT; Tang Y; Wang CJ; Ko SF
    Cancer; 2004 Jan; 100(2):425-32. PubMed ID: 14716781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients.
    Grande GE; Farquhar MC; Barclay SI; Todd CJ
    Palliat Support Care; 2009 Sep; 7(3):289-97. PubMed ID: 19788770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organisation for Research and Treatment of Cancer.
    Efficace F; Innominato PF; Bjarnason G; Coens C; Humblet Y; Tumolo S; Genet D; Tampellini M; Bottomley A; Garufi C; Focan C; Giacchetti S; Lévi F;
    J Clin Oncol; 2008 Apr; 26(12):2020-6. PubMed ID: 18421055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?
    Efficace F; Bottomley A; Coens C; Van Steen K; Conroy T; Schöffski P; Schmoll H; Van Cutsem E; Köhne CH
    Eur J Cancer; 2006 Jan; 42(1):42-9. PubMed ID: 16298522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study.
    Mauer ME; Taphoorn MJ; Bottomley A; Coens C; Efficace F; Sanson M; Brandes AA; van der Rijt CC; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; van den Bent MJ;
    J Clin Oncol; 2007 Dec; 25(36):5731-7. PubMed ID: 18089867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of changes in health-related quality of life scores during curative treatment for esophagogastric cancer.
    Djärv T; Metcalfe C; Avery KN; Lagergren P; Blazeby JM
    J Clin Oncol; 2010 Apr; 28(10):1666-70. PubMed ID: 20194863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy.
    Langendijk JA; Doornaert P; Verdonck-de Leeuw IM; Leemans CR; Aaronson NK; Slotman BJ
    J Clin Oncol; 2008 Aug; 26(22):3770-6. PubMed ID: 18669465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study.
    Efficace F; Therasse P; Piccart MJ; Coens C; van Steen K; Welnicka-Jaskiewicz M; Cufer T; Dyczka J; Lichinitser M; Shepherd L; de Haes H; Sprangers MA; Bottomley A
    J Clin Oncol; 2004 Aug; 22(16):3381-8. PubMed ID: 15310784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer.
    Carey MS; Bacon M; Tu D; Butler L; Bezjak A; Stuart GC
    Gynecol Oncol; 2008 Jan; 108(1):100-5. PubMed ID: 17920108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group.
    Collette L; van Andel G; Bottomley A; Oosterhof GO; Albrecht W; de Reijke TM; Fossà SD
    J Clin Oncol; 2004 Oct; 22(19):3877-85. PubMed ID: 15459209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer.
    Efficace F; Biganzoli L; Piccart M; Coens C; Van Steen K; Cufer T; Coleman RE; Calvert HA; Gamucci T; Twelves C; Fargeot P; Bottomley A;
    Eur J Cancer; 2004 May; 40(7):1021-30. PubMed ID: 15093577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of age on Health-Related Quality of Life (HRQoL) and symptoms among postmenopausal women with breast cancer receiving adjuvant chemotherapy.
    Browall MM; Ahlberg KM; Persson LO; Karlsson PO; Danielson EB
    Acta Oncol; 2008; 47(2):207-15. PubMed ID: 18210297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in health-related quality of life may predict recurrent breast cancer.
    Kenne Sarenmalm E; Odén A; Ohlén J; Gaston-Johansson F; Holmberg SB
    Eur J Oncol Nurs; 2009 Dec; 13(5):323-9. PubMed ID: 19596212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective longitudinal study comparing the impact of external radiation therapy with radical prostatectomy on health related quality of life (HRQOL) in prostate cancer patients.
    van Andel G; Visser AP; Zwinderman AH; Hulshof MC; Horenblas S; Kurth KH
    Prostate; 2004 Mar; 58(4):354-65. PubMed ID: 14968436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term treatment-related symptoms and quality of life: results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup Study.
    Bottomley A; Gaafar R; Manegold C; Burgers S; Coens C; Legrand C; Vincent M; Giaccone G; Van Meerbeeck J; ;
    J Clin Oncol; 2006 Mar; 24(9):1435-42. PubMed ID: 16446322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life and survival in the 2 years after surgery for non small-cell lung cancer.
    Kenny PM; King MT; Viney RC; Boyer MJ; Pollicino CA; McLean JM; Fulham MJ; McCaughan BC
    J Clin Oncol; 2008 Jan; 26(2):233-41. PubMed ID: 18086802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life up to six years after (125)I brachytherapy for early-stage prostate cancer.
    Roeloffzen EM; Lips IM; van Gellekom MP; van Roermund J; Frank SJ; Battermann JJ; van Vulpen M
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1054-60. PubMed ID: 20097486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychological coping style versus disease extent, tumour treatment and quality of life in successfully treated head and neck squamous cell carcinoma patients.
    Aarstad AK; Aarstad HJ; Bru E; Olofsson J
    Clin Otolaryngol; 2005 Dec; 30(6):530-8. PubMed ID: 16402979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.